|
|
||||||||
Division of Pulmonary and Critical Care Medicine, Department of Medicine, Veterans Affairs Medical Center, and Indiana University School of Medicine, Indianapolis, Indiana 46202
Pneumonia remains one of the most common infectious causes of mortality. Patients with pneumonia develop parapneumonic effusions with a high neutrophil count as well as high protein concentrations. We hypothesized that pulmonary parenchymal bacterial infection causes a permeability change in the pleural mesothelium by inducing the production of vascular endothelial growth factor (VEGF). Complicated parapneumonic pleural effusions (empyema) have a 19-fold higher VEGF level than pleural fluids secondary to congestive heart failure and a 4-fold higher level than pleural fluids secondary to uncomplicated parapneumonic effusions. We also analyzed the influence of live Staphylococcus aureus on mesothelial barrier function using a model of confluent mesothelial monolayers. There was a significant drop in electrical resistance across S. aureus-infected pleural mesothelial cell (PMC) monolayers. Recombinant VEGF also decreases PMC electrical resistance. Neutralizing antibodies to VEGF significantly inhibited the drop in PMC electrical resistance caused by S. aureus. S. aureus infection also caused a significant increase in protein leak across confluent mesothelial monolayers. Our results suggest that bacterial pathogens induce VEGF release in mesothelial cells and alter mesothelial permeability, leading to protein exudation in empyema.
vascular endothelial growth factor; mesothelial cells; protein permeability
This article has been cited by other articles:
![]() |
T. Hussain, N. Nasreen, Y. Lai, B. F. Bellew, V. B. Antony, and K. A. Mohammed Innate immune responses in murine pleural mesothelial cells: Toll-like receptor-2 dependent induction of {beta}-defensin-2 by staphylococcal peptidoglycan Am J Physiol Lung Cell Mol Physiol, September 1, 2008; 295(3): L461 - L470. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. B. Guo, I. Kalomenidis, M. Hawthorne, K. S. Parman, K. B. Lane, and R. W. Light Pleurodesis Is Inhibited by Anti-Vascular Endothelial Growth Factor Antibody Chest, September 1, 2005; 128(3): 1790 - 1797. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Sack, M. Hoffmann, X. J. Zhao, K. S. Chan, D. S. C. Hui, H. Gosse, L. Engelmann, J. Schauer, F. Emmrich, and G. Hoheisel Vascular endothelial growth factor in pleural effusions of different origin Eur. Respir. J., April 1, 2005; 25(4): 600 - 604. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Kilani, K. A. Mohammed, N. Nasreen, J. A. Hardwick, M. H. Kaplan, R. S. Tepper, and V. B. Antony Respiratory Syncytial Virus Causes Increased Bronchial Epithelial Permeability Chest, July 1, 2004; 126(1): 186 - 191. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. K. Sharma, K. A. Mohammed, N. Nasreen, J. Hardwick, R. D. Van Horn, C. Ramirez-Icaza, and V. B. Antony Defensive Role of Pleural Mesothelial Cell Sialomucins in Tumor Metastasis Chest, August 1, 2003; 124(2): 682 - 687. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |